A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon
A. H. Malik, K. S. Kumar, P. F. Malet, G. Ostapowicz, G. Adams, M. Wood, K. Yarbrough, A. Jones, W. M. LeeVolume:
16
Year:
2002
Language:
english
Pages:
8
DOI:
10.1046/j.1365-2036.2002.01201.x
File:
PDF, 157 KB
english, 2002